RE:RE:Added another 12K with bidding at 1.89Yearninyank,
If KNR was only dependent on BioCloud product, I wouldn't invest heavily. However, they have another core business with 12-13 million revenue over the last three years. Based on company's low outstanding shares (around 44 million) and major ownership of the outstanding shares by the insiders, this seems to be a safe investment. If they get any sale order from Biocloud, then the stock price would easily be doubleld.
Finally, I have invested for the last 28 years, so I am not new to the investment community and know its related risks. One big lesson that I learned is that DON"T put your money in investment if you can not afford to lose and another one is to be REALISTIC with your return expectation. In other words, DREAMING should be out of investment practice.
GO KNR GO